Education
About Us
Working with TipRanks
Follow Us
Aspen Pharmacare Holdings Limited (APNHF)
OTHER OTC:APNHF
Total Valuation
Aspen Pharmacare Holdings has a market cap or net worth of $2.95B. The enterprise value is ―.
Market Cap$2.95B
Enterprise Value―
Share Statistics
Aspen Pharmacare Holdings has 446,252,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding446,252,320
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aspen Pharmacare Holdings’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.28%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.28%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee5.04M
Profits Per Employee789.22K
Employee Count8,867
Asset Turnover0.32
Inventory Turnover1.40
Valuation Ratios
The current PE Ratio of Aspen Pharmacare Holdings is 22.33. Aspen Pharmacare Holdings’s PEG ratio is -0.98.
PE Ratio22.33
PS Ratio0.00
PB Ratio1.18
Price to Fair Value1.16
Price to FCF58.30
Price to Operating Cash Flow16.27
PEG Ratio-0.98
Income Statement
In the last 12 months, Aspen Pharmacare Holdings had revenue of 44.71B and earned 4.40B in profits. Earnings per share was 9.91.
Revenue44.71B
Gross Profit19.45B
Operating Income7.00B
Pretax Income5.71B
Net Income4.40B
EBITDA9.91B
Earnings Per Share (EPS)9.91
Cash Flow
In the last 12 months, operating cash flow was 6.16B and capital expenditures -4.46B, giving a free cash flow of 1.72B billion.
Operating Cash Flow6.16B
Free Cash Flow1.72B
Free Cash Flow per Share3.85
Dividends & Yields
Aspen Pharmacare Holdings pays an annual dividend of $0.204, resulting in a dividend yield of 2.2%
Dividend Per Share$0.204
Dividend Yield2.2%
Payout Ratio37.02%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-29.67%
50-Day Moving Average8.78
200-Day Moving Average9.89
Relative Strength Index (RSI)50.56
Average Volume (3m)0.00
Important Dates
Aspen Pharmacare Holdings upcoming earnings date is Sep 3, 2025, TBA Not Confirmed.
Last Earnings DateMar 3, 2025
Next Earnings DateSep 3, 2025
Ex-Dividend DateSep 18, 2024
Financial Position
Aspen Pharmacare Holdings as a current ratio of 1.81, with Debt / Equity ratio of 42.96%
Current Ratio1.81
Quick Ratio1.07
Debt to Market Cap0.36
Net Debt to EBITDA2.43
Interest Coverage Ratio3.14
Taxes
In the past 12 months, Aspen Pharmacare Holdings has paid 1.31B in taxes.
Income Tax1.31B
Effective Tax Rate0.23
Enterprise Valuation
Aspen Pharmacare Holdings EV to EBITDA ratio is 12.35, with an EV/FCF ratio of 177.49.
EV to Sales2.74
EV to EBITDA12.35
EV to Free Cash Flow177.49
EV to Operating Cash Flow19.67
Balance Sheet
Aspen Pharmacare Holdings has $12.34B in cash and marketable securities with Rs36.46B in debt, giving a net cash position of $24.12B billion.
Cash & Marketable Securities$12.34B
Total DebtRs36.46B
Net Cash$24.12B
Net Cash Per Share$54.05
Tangible Book Value Per Share$31.11
Margins
Gross margin is 43.52%, with operating margin of 15.65%, and net profit margin of 9.85%.
Gross Margin43.52%
Operating Margin15.65%
Pretax Margin12.78%
Net Profit Margin9.85%
EBITDA Margin22.18%
EBIT Margin17.76%
Analyst Forecast
The average price target for Aspen Pharmacare Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―